| Website | aberdare.com |
| @AberdareVenture | |
| Phone | 415-392-7442 |
| Employees | |
| Description | Healthcare-focused Venture |
Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.
| Company | Date | Round | Size | Participants |
| Cervel Neurotech | 4/13 | Venture Round | $14.1M | 2 |
| Aviir | 2/13 | Series F | $10M | 4 |
| goBalto | 12/12 | Series B | $12M | 4 |
| MC10 | 12/12 | Series C | $10M | 7 |
| Wello | 11/12 | Seed | $1M | 7 |
| RxAnte | 9/12 | Series A | 2 | |
| Jiff | 3/12 | Series A | $7.5M | 3 |
| HemaQuest Pharmaceuticals | 3/12 | Series B | $13M | 5 |
| MC10 | 1/12 | Venture Round | $2M | 1 |
| Omada Health | 12/11 | Seed | $800k | 5 |
| Aviir | 12/11 | Series E | $10M | 4 |
| NxThera | 10/11 | Series B | $21.6M | 3 |
| Nevro | 7/11 | Venture Round | $58M | 7 |
| Conatus Pharmaceuticals | 2/11 | Series B | $20M | 6 |
| Rock Health | 1/11 | Grant | $500k | 6 |
| HemaQuest Pharmaceuticals | 4/10 | Series B | $12M | 4 |
| Aviir | 1/10 | Debt | $4.2M | 3 |
| Posit Science | 12/09 | Venture Round | $2.4M | 3 |
| Clovis Oncology | 5/09 | Series A | $145M | 7 |
| Posit Science | 4/09 | Series C | $5.6M | 3 |
| Anacor Pharmaceutical | 1/09 | Series E | $50M | 6 |
| Aviir | 10/07 | Series B | $11.3M | 3 |
| Paracor Medical | 6/07 | Series D | $44M | 8 |
| Sequoia Pharmaceuticals | 1/07 | Series C | $35M | 5 |
| KAI Pharmaceuticals | 5/06 | Series B | $35M | 7 |
| Mpex Pharmaceuticals | 8/05 | Series B | $32M | 6 |
| Anacor Pharmaceutical | 5/05 | Series C | $25M | 5 |
| Sequoia Pharmaceuticals | 3/05 | Series B | $22M | 4 |
